United Therapeutics Corp.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $1.18B | $5.36B | $813.3M |
| Jun 2022 | $1.22B | $5.54B | $795.2M |
| Sep 2022 | $1.22B | $5.78B | $966.8M |
| Dec 2022 | $1.25B | $6.04B | $961.2M |
| Mar 2023 | $1.22B | $6.35B | $1.16B |
| Jun 2023 | $1.27B | $6.68B | $1.07B |
| Sep 2023 | $1.31B | $7.02B | $1.11B |
| Dec 2023 | $1.18B | $7.17B | $1.21B |
| Mar 2024 | $1.16B | $6.50B | $1.25B |
| Jun 2024 | $1.03B | $6.72B | $1.36B |
| Sep 2024 | $1.02B | $7.12B | $1.55B |
| Dec 2024 | $920.0M | $7.36B | $1.70B |
| Mar 2025 | $936.7M | $7.74B | $1.90B |
| Jun 2025 | $734.4M | $7.91B | $1.59B |
| Sep 2025 | $760.9M | $7.35B | $1.34B |
| Dec 2025 | $783.8M | $7.88B | $1.56B |
| Mar 2026 | $813.1M | $6.71B | $1.28B |
| Jun 2026 | $819.8M | $7.22B | $1.80B |